ArticleAnnals of hematology2021

Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA).

Massimo Breccia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.